Pricing Log in Create free account

Actuate Therapeutics, Inc. (ACTU) vs Cocrystal Pharma, Inc. (COCP)

Actuate Therapeutics, Inc. and Cocrystal Pharma, Inc. are both Biotechnology companies. Actuate Therapeutics, Inc. and Cocrystal Pharma, Inc. are of similar size ($19.3M and $18.0M). Actuate Therapeutics, Inc. has the higher net margin (0.00% vs −747.8%) and the higher return on invested capital (0.00% vs 0.00%). Across the 11 metrics below, Actuate Therapeutics, Inc. leads on 8 and Cocrystal Pharma, Inc. on 3.

Valuation

Metric ACTU COCP Biotechnology median
P/E n/m n/m 10.60
P/S n/m 10.69 9.40
P/B 7.72 13.60 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales n/m 9.00 9.02
Earnings yield (271.88%) (73.79%) (32.88%)
Free cash flow yield (259.67%) (56.09%) (23.13%)

Profitability

Metric ACTU COCP Biotechnology median
Gross margin — 9.10% 68.51%
Operating margin 0.00% (760.72%) 0.00%
Net margin 0.00% (747.78%) 0.00%
Free cash flow margin 0.00% (598.50%) 0.00%
Return on equity 2,457.65% (311.68%) (51.96%)
Return on assets (336.18%) (151.10%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ACTU COCP Biotechnology median
Revenue growth (TTM) — (30.38%) 6.76%
EPS growth (last fiscal year) 67.48% 54.65% 29.88%
Revenue growth, 5-year CAGR — (33.30%) 9.75%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric ACTU COCP Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 1.25 1.24 4.97
Net debt to EBITDA 0.59 0.82 1.01

Dividend

Metric ACTU COCP Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric ACTU COCP Biotechnology median
Market cap 17.98m 19.27m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack